International Journal of Nephrology / 2018 / Article / Tab 4

Research Article

Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders

Table 4

Scenario sensitivity analyses results.

No.VariableBase case input valueSensitivity input valueICER (Cost (RM) per QALY gained)

1aUndiscounted cost and outcomes3%0%48,033
1b5% discount rate3%5%47,419
2a3-year time horizon60 years3 years25,438
2b10-year time horizon60 years10 years47,586
3aHigh sevelamer dose2.184g4.8g65,210
3bHigh CaCO3 dose2.95g7.5g47,325
4Low dialysis utility0.80.7251,086
5aLow HD costRM259.09RM197.4840,627
5bHigh HD costRM259.09RM350.0058,084
6Exclude dialysis costRM259.09014,407

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.